Introduction
============

A variety of Gram-positive and Gram-negative bacteria are capable of producing compounds with antimicrobial activity that inhibits the growth of other bacteria -- bacteriocins. Simple bacteriocins are chemically small- or medium-sized peptides or proteins. They are ribosomally synthetized and usually undergo post-translational modification. Their activity is directed against related species or even against bacteria of the same strain ([@B30]). Bacteriocins are synthetized by many bacterial species, including lactic acid bacteria (LAB). Apart from bacteriocins, LAB produce organic acids, such as lactic and acetic acids, hydrogen peroxide, or diacetyl. All these compounds have antimicrobial properties, which underlies the use of LAB in the food industry as inhibitors of food-borne pathogens (probiotic cultures). LAB bacteriocins have the potential to be used in food biopreservation ([@B10]). At this time, only nisin, as the most well-studied and best-known bacteriocin, has been approved for use in the food industry ([@B23]).

*Mycobacterium avium* subsp. *paratuberculosis* (MAP) causes an infectious and chronic disease in ruminants called paratuberculosis. The clinical phase is characterized by diarrhea, emaciation, and low milk yield, and is preceded by a long, latent phase (years) during which other, healthy animals can be infected. Therefore, the disease is mostly of importance in cattle herds. Infected animals can shed MAP in milk ([@B27]). This is of public concern due to the possible ingestion of MAP and its potential link to Crohn's disease ([@B15]; [@B3]). In the past, many studies investigated the ability of MAP to survive unfavorable conditions in dairy products; however, their results were not always consistent. Ability of MAP to survive pasteurization process was demonstrated in many studies ([@B12]; [@B2]), but the others did not confirm it ([@B26]). Similarly, it applies to the fermentation process. MAP is capable to surive fermentation ([@B7]; [@B14]), but on the other hand, it is evident that its growth is suppressed during the fermentation and storage of milk products such as cheese ([@B28]; [@B7]; [@B14]) or yogurts ([@B29]; [@B16]). As the role of MAP in Crohn's disease is still not clear, reducing exposure of consumers thought reducing MAP contamination in food is desirable.

Utilization of propidium monoazide treatment followed by real-time PCR based on the amplification of the *F57* fragment (PMA qPCR) was previously employed to study MAP viability after exposure to diverse conditions ([@B24]; [@B17]). The method combines the advantages of cultivation and qPCR. Results are obtained quickly, and the method is sensitive, specific, and provides quantitative data. The PMA dye selectively penetrates dead cells with compromised membranes and covalently binds to its DNA. After photoactivation of the dye (exposure to bright light), it forms insoluble complex with DNA and prevents its amplification in subsequent PCR. At the same time, the excess dye, which has not penetrated into the damaged cells, is inactivated by light. The portion of viable cells is then calculated as the quotient of PMA-treated stressed cells and the control ([@B22]; [@B18]). Previous reports have shown that the experimentally determined difference between completely live and dead (heat-treated) MAP cells using PMA qPCR is about 2 log~10~ ([@B18]). As viability determination using culture and PMA qPCR has been described to yield comparable results, the latter can be applied for the determination of MAP viability as the sole method ([@B24]).

In previous publications, the effect of whole milk products (yogurts, acidophilus milk, etc.) containing LAB and the products of their metabolism on the viability of mycobacteria was studied ([@B29]; [@B16]). The aim of this current study was to assess the viability of three MAP isolates after exposure to filtered cell-free supernatants (CFSs) acquired by the propagation of LAB cultures in their respective media in accordance with standard culture procedures. This procedure was chosen in order to mimic the influence of LAB compounds during the production and storage of fermented products. In addition to CFS, the effects of different concentrations of commercially synthetized nisin and one concentration of lactic acid (LA) on MAP viability were assessed. The viability of MAP strains and isolates was measured using the culture-independent method consisting of treatment with PMA combined with specific qPCR.

Materials and Methods {#s1}
=====================

Bacterial Isolates and Culture Conditions
-----------------------------------------

The MAP laboratory strain CAPM 6381 (The Collection of Animal Pathogenic Microorganisms, Veterinary Research Institute, Czechia) and field isolates 7082 (white deer) and NL-3 (cattle) were used throughout the whole study. All strains and isolates were of RFLP type C1.

All strains and isolates were grown on Herrold's egg yolk medium (HEYM) with penicillin G, chloramphenicol, and amphotericin B (Becton Dickinson, Franklin Lakes, NJ, United States), supplemented with 2 μg/ml Mycobactin J (Allied Monitor, Fayette, MO, United States) at 37°C for 2--3 months until visible colonies were observed. Afterward, grown colonies were harvested using a loop and resuspended in 1.5 ml of Middlebrook 7H9 (M7H9) broth supplemented with 10% (vol/vol) Middlebrook OADC enrichment (both Becton Dickinson, Franklin Lakes, NJ, United States). In order to homogenize the MAP suspensions, 12 1-mm zirconia/silica beads (Biospec, Bartlesville, OK, United States) were added followed by vortexing for 30 s. To remove the MAP clumps, the suspension was centrifuged at 100 × *g* for 30 s and the upper cell fraction was resuspended in fresh M7H9 broth. The suspension was diluted to OD~600~ ≈ 0.15--0.20, which corresponds to approximately 10^8^ MAP cells/ml of suspension ([@B19]).

Preparation of Milk Starter Cultures for CFS
--------------------------------------------

Nine bacterial strains used as milk starter cultures originating from the Lactoflora^®^ collection of milk cultures (Milcom, Prague, Czechia) were propagated in their respective media -- M17 and MRS broth (both Oxoid CZ, Brno, Czechia). Each culture was characterized in detail with respect to its culture conditions, active acidity, and production of bacteriocins (**Table [1](#T1){ref-type="table"}**). The type of bacteriocin was determined by the well method, PCR, or a combination of both. Each milk starter culture was cultured in 250 ml of its respective medium for 18 h. Afterward, the culture of starter bacteria was filtered through a 0.22-μm microbiological filter to prepare CFS. The sterilized, filtered CFSs were subsequently applied to MAP strains and isolates to determine their influence on MAP viability over time.

###### 

Characteristics of milk starter cultures used in this study.

  No.   Strain     Species                                Culture conditions   Active acidity   Bacteriocin production   
  ----- ---------- -------------------------------------- -------------------- ---------------- ------------------------ -------------
  S1    CCDM 731   *Lactococcus lactis* subsp. *Lactis*   37°C 18 h            M17 broth        4.65                     Nisin
  S2    CCDM 857   *Enterococcus faecalis*                                     M17 broth        4.51                     Enterocin
  S3    CCDM 108   *Lactobacillus helveticus*                                  MRS broth        4.14                     Enterocin
  S4    RL 26-P    *Lactobacillus plantarum*                                   MRS broth        3.67                     Plantaricin
  S5    CCM 7165   *Enterococcus faecium*                                      M17 broth        4.68                     Enterocin
  S6    RL 23-P    *Lactobacillus* sp.                                         MRS broth        4.11                     Plantaricin
  S7    CCDM 768   *Lactobacillus helveticus*                                  MRS broth        4.07                     Enterocin
  S8    CCDM 182   *Lactobacillus plantarum*                                   MRS broth        3.81                     Plantaricin
  S9    RL 22-P    *Lactobacillus gasseri*                                     MRS broth        4.51                     Plantaricin
                                                                                                                         

Nisin and LA Preparation
------------------------

In order to mimic the effect of bacteriocins and reduced pH separately, MAP suspensions were exposed to nisin and solutions of LA. Commercially available nisin (Sigma, St. Louis, MO, United States) was diluted in water and added to the M7H9 media to prepare solutions with final concentrations of 0.1, 1, 10, 100, and 1000 μg of nisin/ml of M7H9. A solution of LA was diluted in M7H9 media to a concentration of 5% (v/v) and the pH was adjusted to 3. This value was chosen with respect to the pH of CFS and previous studies ([@B16]).

Exposure of Antimicrobial Substances on the Viability of MAP Strains and Isolates
---------------------------------------------------------------------------------

On day 0, 6 ml of each of the three MAP strains and isolates prepared as described above was aliquoted into 16 tubes (nine milk culture starters, five concentrations of nisin, LA treatment, and control) in biological triplicates. All the tubes were centrifuged at 7000 × *g* for 3 min and the supernatant was replaced by 6 ml of filtered CFS, solutions of nisin, and LA (or respective medium -- MRS or M17 broth as a control sample). All the samples were placed in an incubator set at 37°C. In order to mimic the influence of antimicrobial compounds on MAP viability during the storage of the fermented product, all samples were taken on days 4, 8, and 12.

PMA Treatment
-------------

The viability of MAP after exposure to conditions suppressing bacterial growth, which are induced by fermentation and last during the production and maturation of the fermented product, was determined by the PMA procedure combined with subsequent *F57* qPCR ([@B18], [@B17]; [@B24]). On each sampling day (days 4, 8, and 12), 3× 0.5-ml aliquots were taken from each sample (technical triplicates). All samples were centrifuged (7000 × *g* for 3 min) and the supernatant was replaced with fresh medium. To each 500 μl sample (including controls), 12.5 μl of 1 mM PMA (Biotium Inc., Hayward, CA, United States) stock solution dissolved in 20% DMSO was added (final concentration 25 μM). The mixture was incubated in the dark for 5 min with mixing at 20 Hz and then placed on ice and exposed to light from a 650-W halogen bulb (B&H Photo Video, New York, NY, United States) for 2 min. The whole process of incubation in the dark and light exposure was repeated once again with a freshly added aliquot of PMA. After the PMA treatment, the samples were centrifuged at 7000 × *g* for 3 min and the supernatant was replaced with 500 μl of Tris-EDTA (TE) buffer supplemented with 50 ng/μl of fish sperm DNA (both SERVA Electrophoresis, Heidelberg, Germany). The MAP cells were lysed by incubation at 100°C for 20 min, and after centrifugation at 18,000 × *g* for 5 min, the supernatant served as a template for the qPCR.

F57 qPCR
--------

Quantification of MAP cells for the purposes of viability determination was performed using a qPCR assay amplifying the single copy fragment *F57* according to a calibration curve based on serial dilution of a plasmid gradient on a LightCycler 480 instrument (Roche Molecular Diagnostic, Germany; [@B27]). MAP viability was determined as the quotient of absolute numbers of PMA-exposed stress factor-treated cells (treated with CFS, nisin, or LA) and the PMA-exposed control (stress factor untreated; MAP in the respective broth) cells ([@B18], [@B17]; [@B24]).

Statistical Analysis
--------------------

All the statistical calculations were performed using Statistica 13.0 software (StatSoft, Tulsa, OK, United States). Three-way ANOVA (with factors CFS, time, strain and CFS, time, concentration, respectively) was used for statistical evaluation of the effect of CFS and nisin, respectively, on MAP strain viability. For the determination of LA influence on MAP viability, two-way ANOVA was used (with factors time and strain). *P*-values \<0.05 were considered statistically significant.

Results
=======

Effect of CFS on MAP Viability
------------------------------

Based on their impact on MAP viability, two groups of CFS could be distinguished. Application of S3, S4, S6, S7, S8, and S9 CFS caused a significant reduction in the number of surviving cells (at least 2 log~10~, i.e., below 1%), while in the case of the group containing S1, S2, and S5 CFS the viability reduction was about maximum 1 log~10~ (**Figure [1](#F1){ref-type="fig"}**). CFS could therefore be divided into effective (S3, S4, S6, S7, S8, and S9) and less effective (S1, S2, and S5), with a discriminatory value for classification into one or the other group of 1% (this corresponds to an average decrease in the number of surviving cells of 2 log~10~). To demonstrate the effect of effective and less effective CFS, ANOVA with three factors (CFS, time, and strain) was performed.

![Effect of supernatants on *Mycobacterium avium* subsp. *paratuberculosis* (MAP) viability. **(A)** Field isolate 7082 (white deer); **(B)** collection strain 6381; **(C)** field isolate NL-3 (cattle). Vertical bars represent sample standard deviations. The portion of viable cells is calculated as the quotient of PMA-treated stressed cells (supernatants) and the PMA-treated control (stress factor untreated; MAP in the respective broth).](fmicb-09-00638-g001){#F1}

In the group of effective CFS, it was shown that while there was no statistically significant difference between the strains (*P* \> 0.05, *F*-test), the CFS and the time factor were statistically significant variables (*P* \< 0.01 and *P* \< 0.05, respectively). The interaction of CFS and strain was also significant (*P* \< 0.05). Subsequent testing confirmed that there was a significant difference between S4 and S6 (*P* \< 0.05; Tukey's HSD test) and between S6 and S8 (*P* \< 0.05). In the case of the time factor, a statistically significant difference between days 4 and 8 (*P* \< 0.05) was demonstrated.

No difference was found among the CFS in the less effective group (*P* \> 0.05; *F*-test). The strain and the time factor were statistically significant variables here (both *P* \< 0.01) as well as all factor interactions. Significant differences between NL-3 and 6381 (*P* \< 0.01; Tukey's HSD test) and 6381 and 7082 (*P* \< 0.05) isolates were proven (**Figure [1](#F1){ref-type="fig"}**). Statistically significant differences between days 4 and 12 and between days 8 and 12 (in both cases *P* \< 0.01) were also evident (**Figure [1](#F1){ref-type="fig"}**).

Effects of Nisin and LA on MAP Viability
----------------------------------------

Three-way ANOVA (time, strain, and concentration) was used to estimate the influence of nisin on MAP viability. There was no statistically significant impact of nisin exposure on any of the MAP isolates, despite the fact that the concentrations of nisin covered a larger than 5 log~10~ range (10^-1^--10^3^ μg/ml; **Figure [2](#F2){ref-type="fig"}**).

![Effect of nisin on MAP viability. **(A)** Field isolate 7082 (white deer); **(B)** collection strain 6381; **(C)** field isolate NL-3 (cattle). Vertical bars represent sample standard deviations. The portion of viable cells is calculated as the quotient of PMA-treated stressed cells (nisin) and the PMA-treated control (stress factor untreated; MAP in the respective broth).](fmicb-09-00638-g002){#F2}

The percentage of surviving MAP cells was reduced by less than 2 log~10~ after LA exposure. With respect to CFS, the LA would thus be described as less effective. The percentage of surviving cells decreased over time for all strains (**Figure [3](#F3){ref-type="fig"}**). Both strain and time factors were statistically significant (*P* \< 0.01; *F*-test). Difference between days 4 and 8 and between days 4 and 12 was confirmed (*P* \< 0.01; Tukey's HSD test). The response of the NL-3 isolate was significantly different to those of CAPM 6381 and 7082 isolate (*P* \< 0.01 for NL-3 and 7082). LA was approximately twice as effective in killing NL-3 MAP cells after 4 days compared with the other two isolates. At later stages of the experiment (days 8 and 12), the efficacy of MAP cell killing was equal in all strains (**Figure [3](#F3){ref-type="fig"}**).

![Effect of LA on viability of three MAP isolates. Vertical bars represent sample standard deviations. The portion of viable cells is calculated as the quotient of PMA-treated stressed cells (LA) and the PMA-treated control (stress factor untreated; MAP in the respective broth).](fmicb-09-00638-g003){#F3}

Discussion
==========

All CFS exerted a significant effect on MAP viability. However, their effects were either more (S3, S4, S6, S7, S8, and S9) or less effective (S1, S2, and S5). No viable MAP were found after 4 days of culture with effective CFS. The effective CFSs were products of *Lactobacillus* sp., while enterococci and *Lactococcus lactis* subsp. *lactis* were producers of the less effective CFS group (**Table [1](#T1){ref-type="table"}**). In the previous study, addition of CFS from a number of *Lb. paracasei* isolates delayed the growth of MAP. Application of CFS from *Lb. casei* and *Lb. rhamnosus* led to suppression of the increase in growth typical for MAP metabolic activity ([@B8]). [@B11] showed CFS from *Lb. acidophilus* and *Lb. reuteri* significantly decreased viability of vegetative cells and spores of *Cryptosporidium parvum*. [@B9] also tested the effect of various CFS derived from LAB on MAP viability; one strain of *Lb. plantarum* elicited a significant decrease in MAP intracellular pH and led to loss of its viability. The *Lb. plantarum* strain produced plantaricin, while the others, not effective LAB strains contained enterocins ([@B9]). In consistence with [@B9], plantaricins were exclusively covered in the group of effective CFS in our case and showed significant decrease in MAP viability. On the other hand, the group of effective CFS also included enterocins, which were nevertheless covered in the group of less effective CFS as well (**Table [1](#T1){ref-type="table"}**). It is known that different enterocins show different inhibitory spectra toward selected LAB and pathogens ([@B21]). This could explain different effect of various enterocins on MAP viability within this study (effective and less effective CFS). The differing inhibitory effects of enterocins on MAP could probably be also explained by different LAB producers. While effective enterocins (and plantaricins as well) were produced only by lactobacilli (*Lb. helveticus*, *Lb. plantarum*, *L. gasseri*, and *Lb.* sp.), less effective enterocins and nisin were synthetized by *Lactococcus* and enterococci (**Table [1](#T1){ref-type="table"}** and **Figure [1](#F1){ref-type="fig"}**).

pH values differed slightly between the two groups. Values of around 4 or slightly lower were observed in the effective group of CFS (except for S9 with its limit value), while values between 4.5 and 5.0 were measured in the less effective group. The correlation between pH and bacteriocin activity was observed previously by [@B21]. They found that the activity and stability of enterocins are higher at low pH. This can be ascribed to the solubility of enterocins which is increasing with decreasing pH ([@B21]). [@B16] described a significant inhibition of MAP growth when pH values of fermented milk products dropped below 4. The production of organic acids and subsequent lowering of pH were shown to be the main inhibitory mechanism of bifidobacteria toward Gram-negative bacteria in another study. According to the authors, the bacteriocins of bifidobacteria have only negligible effect on Gram-negative bacteria compared to the production of organic acids and lowering of pH ([@B20]). On the contrary, another study suggested that the inhibitory effect of lactobacilli themselves rather than acid production is responsible for MAP growth delay ([@B8]). The same observations were made by [@B29] who did not note any changes in MAP counts after storage of commercial yogurts (low pH) with inoculated MAP. Thus, the question of whether bacteriocins or pH have the critical impact on MAP viability is still open. Based on the results with CFS themselves, it seems that the type of bacteriocin, the length of its action, LAB production strain, and pH are all involved in the inhibition of MAP growth.

A vast range of nisin concentrations (0.1--1000 μg of nisin/ml media) was selected to cover the maximal range of concentrations. Nevertheless, there was almost no decrease in MAP viability at any concentration (**Figure [2](#F2){ref-type="fig"}**). In the study using alamarBlue reagent, the effect of various concentrations of nisin on *M. kansasii*, *M. tuberculosis*, and MAP viability was examined. Nisin showed good efficacy against MAP, but 60 μg/ml, the highest concentration tested, was below the MIC~90~ for MAP and *M. tuberculosis* ([@B1]). Inhibition of *M. smegmatis* growth was observed at a nisin concentration of 10 μg/ml; a much higher concentration (2500 μg/ml) was needed for *M. tuberculosis* ([@B4]). By measuring intracellular pH, a large decrease in viable MAP cells using 2.5 kU/ml (recounted as 2500 μg/ml) of nisin was showed. After 30 min, no viable cells were detected ([@B9]). According to these previous findings, it seems that nisin concentrations markedly above 1000 μg/ml would be needed for any substantial decrease in MAP viability. However, taking into account the study of [@B1], at least some reduction in MAP viability had to be attained, but this was not demonstrated at all (**Figure [2](#F2){ref-type="fig"}**). Thus, another interpretation can be used to explain the almost 100% maintenance of viability after several days of treatment with even high concentrations of nisin. The PMA qPCR method is based on the penetration of PMA through pores in bacterial membranes caused by the action of antimicrobial agents. It is known that nisin binds to cytoplasmic membranes and forms pores by inserting through membranes. It was found that pores formed by nisin in *M. bovis* BCG were large enough to leak protons, but too small for ATP ([@B4]). With respect to the relatively large size of the PMA molecule and the small pores formed by nisin, a possible inability of PMA to penetrate through these pores should be considered.

The mechanism of LA antimicrobial activity is based on the passing of its undissociated forms through the cell membrane. Increased cytoplasmic pH leads to the dissociation of the acid, the release of protons, and subsequent acidification of the cytoplasm ([@B6]; [@B25]). It is known that mycobacteria have higher tolerance to acidic environments compared to other bacteria ([@B6]). MAP cells remained culturable for at least 7 days at pH 4 ([@B5]). In fermented milk products with pH values of around 4, MAP remained culturable for even up to 6 weeks ([@B16]). In our study, 5% LA with pH 3 played a role in the reduction of MAP viability; however, it had only a moderate effect. This was evidenced by the presence of 14--25% viable MAP cells after 4 days and at least 5% of viable MAP after 12 days of LA treatment (**Figure [3](#F3){ref-type="fig"}**). With respect to CFS, the effect of LA was comparable to the group of less effective CFS. However, the pH of the LA (pH 3) was closer to the pH value of the effective CFS (below or around 4 mostly) than to the less effective ones (above 4.5). If the pH should have a decisive impact on reducing MAP viability, then its effect should be rather comparable to the group of effective CFS. Thus, it can be assumed that although pH plays an important role in reducing the viability of MAP, a significant decrease in viability below 1% is due to bacteriocins or LAB themselves than to pH.

The effect of LA on 6381 and 7082 strains was not as considerable as on NL-3 after the first 4 days of treatment (**Figure [3](#F3){ref-type="fig"}**). While NL-3 is a field isolate, 6381 is a laboratory strain. MAP 7082 has gone through many passages in the laboratory and therefore it can be expected that its response will rather correspond to the response of laboratory strain. In general, laboratory strains show higher tolerance to stress factors comparing to field isolates ([@B13]; [@B17]), which could explain more successful decrease of viability in NL-3 compared to 6381 and 7082 (**Figure [3](#F3){ref-type="fig"}**). Totally different situation, however, occurred with the NL-3 after its exposure to the CFS No. 5. After 4 and 8 days of the treatment, CFS No. 5 showed negligible effect on NL-3 compared to other CFS from the less effective group (Nos. 1 and 2; **Figure [1](#F1){ref-type="fig"}**). Unexpectedly, NL-3 also showed significantly higher tolerance to CFS No. 5 compared to laboratory strain 6381 and high-passage strain 7082 (**Figure [1](#F1){ref-type="fig"}**). It is unclear why only the effect of CFS No. 5 on the NL-3 viability was so insignificant, and further investigation would be required to clarify this.

To sum up, the effect of filtered CFS acquired by the propagation of LAB cultures, commercially synthetized nisin, and one concentration of LA to the viability of MAP isolates was investigated. All nine CFS showed significant effects on MAP viability. Nevertheless, two distinct groups of effective and less effective CFS could be distinguished. The effective CFSs comprising of six bacteriocins (plantaricins and enterocins) were extracted from various lactobacilli cultures (*Lb. helveticus*, *Lb. plantarum*, *L. gasseri*, and *Lb*. sp.) and their pH values were mostly around 4 (3.6--4.5). Application of these CFS resulted in \>2 log~10~ reduction in MAP viability (below 1% of surviving) and no viable MAP were observed after 4 days of treatment. The group of less effective CFS (enterocins and nisin) were filtered from *L. lactis* subsp. *lactis* and enterococci cultures (*E. faecalis* and *E. faecium*) and their pH values were higher than 4.5. Less effective CFS elicited a reduction in MAP viability of \<2 log~10~. LA applied at a concentration of 5% (pH 3) resulted in a reduction in MAP viability similar to that of the less effective CFS group. After 4 days of treatment, about 14--25% of MAP cells survived; 5% of viable cells was still found after 12 days of LA treatment. On the contrary, almost no effect was found when using commercially synthetized nisin at concentrations of 0.1--1000 μg/ml. It seems that the type of bacteriocin, the length of its action, LAB production strain, and pH are probably all involved in determining the success of MAP viability reduction. Nevertheless, as the effect of LA was comparable to the group of less effective CFS than those effective, it can be assumed that certain bacteriocins and their LAB production strains could play more important role in reducing the viability of MAP than the pH.
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